Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2 Alpha-methyldihydrotestosterone Propionate
2. Drolban
3. Dromostanolone Propionate
4. Masteril
5. Masterone
6. Nsc 12198
7. Nsc-12198
1. Dromostanolone Propionate
2. 521-12-0
3. Permastril
4. Emdisterone
5. Masterid
6. Masteron
7. Blackburn Compound
8. Drolban
9. 2mdtp
10. 2m-dhtp
11. Masteril
12. Masterone
13. Medrotestron Propionate
14. Medrotestrone Propanoate
15. Medrotestrone Propionate
16. Mdht
17. Dromostanolone Proprionate
18. Lilly 32379
19. Re 346
20. Nsc-1298
21. Dromostanolone 17-propionate
22. Rs 1567
23. 2alpha-methyl-4,5-dihydrotestosterone Propionate
24. Testosterone, 4,5alpha-dihydro-2alpha-methyl-, Propionate
25. Nsc-12198
26. 17beta-hydroxy-2alpha-methyl-5alpha-androstan-3-one Propionate
27. X20uz57g4o
28. Chebi:31523
29. Dromostanolone Propionate [usan]
30. [(2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] Propanoate
31. Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2a,5a,17b)-
32. 2.alpha.-methyldihydrotestosterone Propionate
33. 17.beta.-hydroxy-2.alpha.-methyl-5.alpha.-androstan-3-one Propionate
34. 2.alpha.-methyl-4,5-dihydrotestosterone Propionate
35. Drostanolone Propionate (jan)
36. 2alpha-methyl-3-oxo-5alpha-androstan-17beta-yl Propanoate
37. Dromostanolone Propionate (usan)
38. Nomasteron
39. Drostanolone Propionate [jan]
40. (2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxohexadecahydro-1h-cyclopenta[a]phenanthren-17-yl Propionate
41. Drolban (tn)
42. Unii-x20uz57g4o
43. Masteron (tn)
44. Einecs 208-303-1
45. Dromostanolone Propionate [usan:usp]
46. Brn 3161958
47. Ai3-52810
48. Schembl3173
49. Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-
50. 4-08-00-00654 (beilstein Handbook Reference)
51. 17b-hydroxy-2a-methyl-5a-androstan-3-one Propionate
52. Gtpl6947
53. Chembl1201048
54. Dtxsid1022972
55. Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2.alpha.,5.alpha.,17.beta.)-
56. (2alpha,5alpha,17beta)-2-methyl-3-oxoandrostan-17-yl Propanoate
57. Nsc12198
58. Zinc4213057
59. Mfcd01669961
60. S4794
61. Dromostanolone Propionate [mi]
62. Akos015895157
63. Ccg-268166
64. Db14655
65. Drostanolone Propionate [mart.]
66. Ds-3972
67. Drostanolone Propionate [who-dd]
68. Ncgc00507798-01
69. Hy-107344
70. Cs-0028187
71. C15917
72. D01534
73. Dromostanolone Propionate [orange Book]
74. 521d120
75. A828929
76. Q5308606
77. W-105852
78. Drostanolone Propionate 100 Microg/ml In Acetonitrile
79. Testosterone,5.alpha.-dihydro-2.alpha.-methyl-, Propionate
80. Testosterone, 4,5.alpha.-dihydro-2.alpha.-methyl-, Propionate
81. Androstan-3-one,2-methyl-17-(1-oxopropoxy)-,(2
82. A,5
83. A,17
84. A)-
85. 5-alpha-androstan-3-one, 17-beta-hydroxy-2-alpha-methyl-, Propionate
86. 5.alpha.-androstan-3-one, 17.beta.-hydroxy-2.alpha.-methyl-, Propionate
87. Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2alpha,5alpha,17beta)-
88. 2-methyl-3-oxoandrostan-17-yl Propionate, (2.alpha.,5.alpha.,17.beta.)- #
89. Androstan-3-one, 2-methyl-17-(1-oxopropoxy)-, (2.alpha.,5.alpha.,17.beta
90. [(2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxidanylidene-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] Propanoate
91. Propanoic Acid [(2r,5s,8r,9s,10s,13s,14s,17s)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] Ester
| Molecular Weight | 360.5 g/mol |
|---|---|
| Molecular Formula | C23H36O3 |
| XLogP3 | 5.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 360.26644501 g/mol |
| Monoisotopic Mass | 360.26644501 g/mol |
| Topological Polar Surface Area | 43.4 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 598 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
Dromostanolone is a synthetic androgen, or male hormone, similar to testosterone. Dromostanolone works by attaching itself to androgen receptors; this causes it to interact with the parts of the cell involved in the making of proteins. It may cause an increase in the synthesis of some proteins or a decrease in the synthesis of others. These proteins have a variety of effects, including blocking the growth of some types of breast cancer cells, stimulating cells that cause male sexual characteristics, and stimulating the production of red blood cells.
Absorption
Well absorbed following parenteral administration.
Dromostanolone is a synthetic androgenic anabolic steroid and is approximately 5 times as potent as natural methyltestosterone. Like testosterone and other androgenic hormones, dromostanolone binds to the androgen receptor. This causes downstream genetic transcriptional changes. This ultimately causes retention of nitrogen, potassium, and phosphorus; increases protein anabolism; and decreases amino acid catabolism. The antitumour activity of dromostanolone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
